115 related articles for article (PubMed ID: 8856082)
1. A synthetic peptide from the human immunodeficiency virus type-1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Correlated biochemical and spectroscopic results.
Sourgen F; Maroun RG; Frère V; Bouziane M; Auclair C; Troalen F; Fermandjian S
Eur J Biochem; 1996 Sep; 240(3):765-73. PubMed ID: 8856082
[TBL] [Abstract][Full Text] [Related]
2. Helical and coiled-coil-forming properties of peptides derived from and inhibiting human immunodeficiency virus type 1 integrase assessed by 1H-NMR--use of NH temperature coefficients to probe coiled-coil structures.
Krebs D; Maroun RG; Sourgen F; Troalen F; Davoust D; Fermandjian S
Eur J Biochem; 1998 Apr; 253(1):236-44. PubMed ID: 9578482
[TBL] [Abstract][Full Text] [Related]
3. Solution conformation of a peptide corresponding to residues 151-172 of HIV-1 integrase using NMR and CD spectroscopy.
Cheng JW; Cheng CC; Lyu PC; Chen ST; Lin TH
Int J Pept Protein Res; 1996; 47(1-2):117-22. PubMed ID: 8907508
[TBL] [Abstract][Full Text] [Related]
4. Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers.
Maroun RG; Gayet S; Benleulmi MS; Porumb H; Zargarian L; Merad H; Leh H; Mouscadet JF; Troalen F; Fermandjian S
Biochemistry; 2001 Nov; 40(46):13840-8. PubMed ID: 11705373
[TBL] [Abstract][Full Text] [Related]
5. Conformational aspects of HIV-1 integrase inhibition by a peptide derived from the enzyme central domain and by antibodies raised against this peptide.
Maroun RG; Krebs D; Roshani M; Porumb H; Auclair C; Troalen F; Fermandjian S
Eur J Biochem; 1999 Feb; 260(1):145-55. PubMed ID: 10091594
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
Biopolymers; 2010 Aug; 93(8):740-51. PubMed ID: 20517955
[TBL] [Abstract][Full Text] [Related]
7. Circular dichroism and fluorescence of a tyrosine side-chain residue monitors the concentration-dependent equilibrium between U-shaped and coiled-coil conformations of a peptide derived from the catalytic core of HIV-1 integrase.
Porumb H; Zargarian L; Merad H; Maroun R; Mauffret O; Troalen F; Fermandjian S
Biochim Biophys Acta; 2004 Jun; 1699(1-2):77-86. PubMed ID: 15158714
[TBL] [Abstract][Full Text] [Related]
8. A structural study of model peptides derived from HIV-1 integrase central domain.
Maroun RG; Zargarian L; Stocklin R; Troalen F; Jankowski CK; Fermandjian S
Rapid Commun Mass Spectrom; 2005; 19(18):2539-48. PubMed ID: 16106350
[TBL] [Abstract][Full Text] [Related]
9. An unusual helix turn helix motif in the catalytic core of HIV-1 integrase binds viral DNA and LEDGF.
Merad H; Porumb H; Zargarian L; René B; Hobaika Z; Maroun RG; Mauffret O; Fermandjian S
PLoS One; 2009; 4(1):e4081. PubMed ID: 19119323
[TBL] [Abstract][Full Text] [Related]
10. Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity.
Taddeo B; Carlini F; Verani P; Engelman A
J Virol; 1996 Dec; 70(12):8277-84. PubMed ID: 8970947
[TBL] [Abstract][Full Text] [Related]
11. Self-association and domains of interactions of an amphipathic helix peptide inhibitor of HIV-1 integrase assessed by analytical ultracentrifugation and NMR experiments in trifluoroethanol/H(2)O mixtures.
Maroun RG; Krebs D; El Antri S; Deroussent A; Lescot E; Troalen F; Porumb H; Goldberg ME; Fermandjian S
J Biol Chem; 1999 Nov; 274(48):34174-85. PubMed ID: 10567389
[TBL] [Abstract][Full Text] [Related]
12. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
Greenwald J; Le V; Butler SL; Bushman FD; Choe S
Biochemistry; 1999 Jul; 38(28):8892-8. PubMed ID: 10413462
[TBL] [Abstract][Full Text] [Related]
13. Binding aspects of baicalein to HIV-1 integrase.
Ahn HC; Lee SY; Kim JW; Son WS; Shin CG; Lee BJ
Mol Cells; 2001 Aug; 12(1):127-30. PubMed ID: 11561722
[TBL] [Abstract][Full Text] [Related]
14. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex.
Heuer TS; Brown PO
Biochemistry; 1998 May; 37(19):6667-78. PubMed ID: 9578550
[TBL] [Abstract][Full Text] [Related]
15. Characterization of recombinant integrase of human immunodeficiency virus type 1 (isolate Bru).
Semenova EA; Gashnikova NM; Il'ina TV; Pronyaeva TR; Pokrovsky AG
Biochemistry (Mosc); 2003 Sep; 68(9):988-93. PubMed ID: 14606941
[TBL] [Abstract][Full Text] [Related]
16. Peptide fragments of DNA topoisomerase II with helix-forming and coiled-coil-forming properties act as inhibitors of the enzyme.
Frère-Gallois V; Krebs D; Scala D; Troalen F; Fermandjian S
Eur J Biochem; 1997 Oct; 249(1):142-8. PubMed ID: 9363765
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination of non-lysine residues in the retroviral integrase.
Wang Z; Hou X; Wang Y; Xu A; Cao W; Liao M; Zhang R; Tang J
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):57-62. PubMed ID: 29054407
[TBL] [Abstract][Full Text] [Related]
18. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
[TBL] [Abstract][Full Text] [Related]
19. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
Heuer TS; Brown PO
Biochemistry; 1997 Sep; 36(35):10655-65. PubMed ID: 9271496
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 integrase crosslinked oligomers are active in vitro.
Faure A; Calmels C; Desjobert C; Castroviejo M; Caumont-Sarcos A; Tarrago-Litvak L; Litvak S; Parissi V
Nucleic Acids Res; 2005; 33(3):977-86. PubMed ID: 15718297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
